Singderm 1 x 2 ml

Singderm

Dermal Fillers

Hyaluronic Acid Fillers

CE Marked (CE 1023 according to manufacturer) :contentReference[oaicite:23]{index=23}
ISO 13485, ISO 9001 certified manufacturer (per manufacturer data) :contentReference[oaicite:24]{index=24}

CE Marked (CE 1023 according to manufacturer) :contentReference[oaicite:23]{index=23}
ISO 13485, ISO 9001 certified manufacturer (per manufacturer data) :contentReference[oaicite:24]{index=24}

Hyaluronic Acid Fillers

Description

Singderm® is a monophasic hyaluronic‑acid dermal filler, with 24 mg/ml HA and 0.3% lidocaine in physiologic buffer, provided in a 2 ml pre‑filled disposable syringe. It is designed for injection into mid to deep dermis or subcutaneous tissue to correct wrinkles, restore lost facial volume, and improve facial contours. :contentReference[oaicite:0]{index=0}

Bnefits

High HA concentration (24 mg/ml) for effective volume restoration and lift. :contentReference[oaicite:1]{index=1}
Contains 0.3% lidocaine for more comfortable, less painful injections. :contentReference[oaicite:2]{index=2}
Mono‑phasic, smooth gel ensures natural-looking results and good tissue integration. :contentReference[oaicite:3]{index=3}
CE‑marked and produced via microbial fermentation (non‑animal origin HA), reducing risk of immunogenic reactions. :contentReference[oaicite:4]{index=4}
Results can last 6–12 months depending on treatment area, HA amount, and patient metabolism. :contentReference[oaicite:5]{index=5}

Indications

Correction of mid to deep skin depressions, wrinkles and folds (e.g., nasolabial folds, marionette lines). :contentReference[oaicite:6]{index=6}
Restoring age‑related facial volume loss (cheeks, temples, chin). :contentReference[oaicite:7]{index=7}
Lip contouring and volume enhancement. :contentReference[oaicite:8]{index=8}
Facial contouring and reshaping (jawline, cheeks). :contentReference[oaicite:9]{index=9}

Composition

Sodium hyaluronate (cross‑linked HA) 24 mg/ml, non‑animal origin, microbial‑fermentation sourced. :contentReference[oaicite:10]{index=10}
Lidocaine hydrochloride 0.3% for anaesthesia during injection. :contentReference[oaicite:11]{index=11}
Physiologic phosphate buffer, sterile, pyrogen‑free. :contentReference[oaicite:12]{index=12}

Formulation

Monophasic, homogeneous viscous gel suspension with cross‑linked HA and lidocaine. :contentReference[oaicite:13]{index=13}

Packaging

Pre‑filled disposable syringe (2 ml). :contentReference[oaicite:14]{index=14}
Comes with instruction leaflet and traceability labels. :contentReference[oaicite:15]{index=15}

Usage

Intended for use by trained medical professionals only. :contentReference[oaicite:16]{index=16}
Inject into mid to deep dermis or subcutaneous tissue, depending on indication. :contentReference[oaicite:17]{index=17}
Use a separate sterile needle — needles are not included. :contentReference[oaicite:18]{index=18}
Observe standard aseptic and patient‑safety protocols.

Contraindications

Known hypersensitivity to HA or lidocaine
Active skin infection or inflammation at injection site
Pregnancy or breastfeeding (depending on local regulations)

Adverse Effects

Temporary redness, swelling, bruising or mild discomfort at injection site — common with dermal fillers. :contentReference[oaicite:19]{index=19}
Risk of rare complications such as infection, granuloma formation or vascular occlusion (general filler risk). :contentReference[oaicite:20]{index=20}

Storage Conditions

Store at 2–30 °C per manufacturer instructions. :contentReference[oaicite:21]{index=21}
Keep unopened until use; do not reuse or resterilize. :contentReference[oaicite:22]{index=22}